Clinical Trial Update: Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 safety trial evaluating preoperative sunitinib with radiation in soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Heidelberg University | Conditions: Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED